Advisory Board member Ross Camidge takes us through the latest research on ALK inhibitors and other targeted therapies for lung cancer, including updated data from the ALEX trial (8:46).
08-06-2018 | Lung cancer | ASCO 2018 | Video
08-06-2018 | Lung cancer | ASCO 2018 | Video
Advisory Board member Ross Camidge takes us through the latest research on ALK inhibitors and other targeted therapies for lung cancer, including updated data from the ALEX trial (8:46).